Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Helus Pharma Inc (NASDAQ: HELP) closed at $7.53 up 2.17% from its previous closing price of $7.37. In other words, the price has increased by $2.17 from its previous closing price. On the day, 0.57 million shares were traded. HELP stock price reached its highest trading level at $7.7899 during the session, while it also had its lowest trading level at $7.3.
Ratios:
For a deeper understanding of Helus Pharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.58 and its Current Ratio is at 8.58. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.21.
Upgrades & Downgrades
In the most recent recommendation for this company, Guggenheim on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $35.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HELP now has a Market Capitalization of 375702816 and an Enterprise Value of 320838816.
Stock Price History:
The Beta on a monthly basis for HELP is 0.82, which has changed by -0.15393257 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, HELP has reached a high of $10.72, while it has fallen to a 52-week low of $4.81. The 50-Day Moving Average of the stock is 12.74%, while the 200-Day Moving Average is calculated to be 8.41%.
Shares Statistics:
For the past three months, HELP has traded an average of 868.11K shares per day and 929030 over the past ten days. A total of 49.89M shares are outstanding, with a floating share count of 44.31M. Insiders hold about 11.18% of the company’s shares, while institutions hold 24.39% stake in the company. Shares short for HELP as of 1765756800 were 2428271 with a Short Ratio of 2.80, compared to 1763078400 on 2225719.
Earnings Estimates
The dynamic stock of Helus Pharma Inc (HELP) is currently being evaluated by a team of 3.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.79, with high estimates of -$0.73 and low estimates of -$0.87.
Analysts are recommending an EPS of between -$4.0 and -$4.58 for the fiscal current year, implying an average EPS of -$4.29. EPS for the following year is -$4.03, with 4.0 analysts recommending between -$2.73 and -$5.55.
